Advanced Biomed Inc.
ADVB
$1.86
-$0.04-2.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -39.01% | 24.79% | -12.67% | 63.57% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -19.28% | 18.13% | -28.87% | -23.66% | |
| Operating Income | 19.28% | -18.13% | 28.87% | 23.66% | |
| Income Before Tax | -524.85% | 65.56% | 44.50% | 62.30% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -524.85% | 65.56% | 44.50% | 62.30% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -524.85% | 65.56% | 44.50% | 62.30% | |
| EBIT | 19.28% | -18.13% | 28.87% | 23.66% | |
| EBITDA | 26.16% | -19.07% | 32.00% | 32.08% | |
| EPS Basic | -521.92% | 65.54% | 44.79% | 62.18% | |
| Normalized Basic EPS | -531.11% | 65.56% | 44.70% | 62.50% | |
| EPS Diluted | -521.92% | 65.54% | 44.79% | 62.18% | |
| Normalized Diluted EPS | -531.11% | 65.56% | 44.70% | 62.50% | |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.45% | 0.00% | |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.45% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |